Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 25,584	$ 24,071
Marketable securities, short-term	44,863	76,702
Restricted cash	5,764	150
Accounts receivable	21,085	3,633
Inventory	13,327	16,408
Employer retention credit receivable	4,703	0
Prepaid expenses and other current assets	2,541	5,326
Total current assets	117,867	126,290
Marketable securities, long-term	0	7,120
Property and equipment, net	9,221	13,670
Right-of-use asset, net	3,872	4,521
Intangible assets, net	1,583	5,013
Goodwill	0	12,026
Other assets	897	1,152
Total assets	133,440	169,792
Current liabilities:
Accounts payable	4,721	7,519
Accrued liabilities	9,686	9,096
Contingent consideration, short-term	1,800	1,500
Operating lease liabilities, short-term	319	395
Warrant liability	3,346	0
Total current liabilities	19,872	18,510
Operating lease liabilities, long-term	4,103	4,591
Long-term debt	34,434	40,415
Contingent consideration, long-term	0	500
Other long-term liabilities	12	50
Total liabilities	58,421	64,066
Commitments and contingencies (Note 13)
Stockholders' equity
Preferred stock: Series A Common Equivalent Preferred Stock, 0.001 par value; 5,000,000 shares authorized, and 6,666 shares issued and outstanding	0	0
Common stock: 0.001 par value; 260,000,000 shares authorized, 28,554,656 and 27,957,223 issued and outstanding at December 31, 2022 and 2021, respectively	29	28
Additional paid-in capital	594,173	584,613
Accumulated deficit	(518,314)	(478,698)
Accumulated other comprehensive loss	(869)	(217)
Total stockholders' equity	75,019	105,726
Total liabilities and stockholders' equity	$ 133,440	$ 169,792